Literature DB >> 8469341

Polyglucosan body disease simulating amyotrophic lateral sclerosis.

T D McDonald1, P L Faust, C Bruno, S DiMauro, J E Goldman.   

Abstract

We describe two patients with polyglucosan body disease (PBD) with the clinical features of atypical amyotrophic lateral sclerosis (ALS). Patient 1 was demented, and patient 2, of Ashkenazi background, was incontinent of urine. Autopsy of patient 1 revealed diffuse CNS accumulations of polyglucosan bodies (PB) localized primarily in neuronal and astrocytic processes and rarely in neuronal perikarya. PB were present in peripheral nerve and myocardium. Brancher enzyme analysis of nerve and muscle was normal. Patient 2's sural nerve biopsy showed PB. Brancher activity was markedly reduced in nerve but not in leukocytes. Previous reports have shown reduced leukocyte brancher activity in Ashkenazi patients with PBD. Clinically, pathologically, and biochemically, PBD is heterogeneous and may include patients presenting with ALS. Cases in which typical pathologic features of PBD are combined with findings of rare PB in neural perikarya may represent a pathologic variant of PBD. Brancher enzyme activity may be normal or only mildly reduced in leukocytes in Ashkenazi patients with PBD, implying genetic heterogeneity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8469341     DOI: 10.1212/wnl.43.4.785

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

Review 1.  Myopathies Related to Glycogen Metabolism Disorders.

Authors:  Mark A Tarnopolsky
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

2.  [Polyglycosan body myopathy].

Authors:  M Jeub; K Kappes-Horn; C Kornblum; D Fischer
Journal:  Nervenarzt       Date:  2006-12       Impact factor: 1.214

Review 3.  Update on polyglucosan storage diseases.

Authors:  Giovanna Cenacchi; V Papa; R Costa; V Pegoraro; R Marozzo; M Fanin; C Angelini
Journal:  Virchows Arch       Date:  2019-07-30       Impact factor: 4.064

4.  Generation of a novel mouse model that recapitulates early and adult onset glycogenosis type IV.

Authors:  H Orhan Akman; Tatiana Sheiko; Stacey K H Tay; Milton J Finegold; Salvatore Dimauro; William J Craigen
Journal:  Hum Mol Genet       Date:  2011-08-19       Impact factor: 6.150

5.  Frequent misdiagnosis of adult polyglucosan body disease.

Authors:  Mark A Hellmann; Or Kakhlon; Ezekiel H Landau; Menachem Sadeh; Nir Giladi; Ilana Schlesinger; Daphne Kidron; Oded Abramsky; Avinoam Reches; Zohar Argov; Jose M Rabey; Joab Chapman; Hanna Rosenmann; Aya Gal; J Moshe Gomori; Vardiella Meiner; Alexander Lossos
Journal:  J Neurol       Date:  2015-07-21       Impact factor: 4.849

6.  A novel mouse model that recapitulates adult-onset glycogenosis type 4.

Authors:  H Orhan Akman; Valentina Emmanuele; Yasemin Gülcan Kurt; Bülent Kurt; Tatiana Sheiko; Salvatore DiMauro; William J Craigen
Journal:  Hum Mol Genet       Date:  2015-09-18       Impact factor: 6.150

7.  A(a)LS: Ammonia-induced amyotrophic lateral sclerosis.

Authors:  Bhavin Parekh
Journal:  F1000Res       Date:  2015-05-14

8.  First Report on Fetal Cerebral Polyglucosan Bodies in Mucopolysaccharidosis Type VII.

Authors:  Hazim Kadhim; Valérie Segers; Catheline Vilain; Julie Désir; Nicky D'Haene
Journal:  Case Rep Pediatr       Date:  2017-07-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.